Literature DB >> 2270413

Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan.

A Ghafoor1, N K Nomani, Z Ishaq, S Z Zaidi, F Anwar, M I Burney, A W Qureshi, S A Ahmad.   

Abstract

A hospital-based inpatient and outpatient study of 1,492 cases of acute lower respiratory tract infection (ALRI) was conducted from November 1986 to March 1988 in two hospitals in Rawalpindi and Islamabad, Pakistan. Specimens of nasopharyngeal aspirate were processed for viral studies in all cases; blood cultures were performed in 1,331 cases; and urine was obtained for detection of bacterial antigen in 378 cases, but 227 of these samples had bacterial contamination and were discarded. Respiratory syncytial virus was identified in 33% of cases, and Haemophilus influenzae and Streptococcus pneumoniae were identified in 9.6% and 9.9% of cases, respectively. Nonencapsulated H. influenzae accounted for 32% of the Haemophilus isolates, and type b was the only encapsulated H. influenzae strain identified. Of the S. pneumoniae serotypes isolated, 31% are not included in the currently available polyvalent pneumococcal vaccine. No clinical characteristic was demonstrated to be a reliable indicator for bacterial ALRI.

Entities:  

Mesh:

Year:  1990        PMID: 2270413     DOI: 10.1093/clinids/12.supplement_8.s907

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  30 in total

Review 1.  Respiratory syncytial virus infection: clinical presentation and management.

Authors:  J A Patel; K Deka; P L Ogra
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

2.  Frequent Community Use of Antibiotics among a Low-Economic Status Population in Manila, the Philippines: A Prospective Assessment Using a Urine Antibiotic Bioassay.

Authors:  Nobuo Saito; Noriko Takamura; Grace P Retuerma; Carina H Frayco; Paul S Solano; Cherlyn D Ubas; Arianne V Lintag; Maricel R Ribo; Rontgene M Solante; Alexis Q Dimapilis; Elizabeth O Telan; Winston S Go; Motoi Suzuki; Koya Ariyoshi; Christopher M Parry
Journal:  Am J Trop Med Hyg       Date:  2018-03-01       Impact factor: 2.345

3.  Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells.

Authors:  Z Jiang; N Nagata; E Molina; L O Bakaletz; H Hawkins; J A Patel
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan.

Authors: 
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

Review 5.  The current status of community-acquired pneumonia management and prevention in children under 5 years of age in India: a review.

Authors:  Krishna Kumar Yadav; Shally Awasthi
Journal:  Ther Adv Infect Dis       Date:  2016-07-04

Review 6.  Acute respiratory infection: a global challenge.

Authors:  H Campbell
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

Review 7.  Classification and treatment of pneumonia.

Authors:  R Bahl; N Bhandari; M K Bhan
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

Review 8.  Mixed viral infections: detection and management.

Authors:  J L Waner
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 9.  The epidemiology of pneumococcal infection in children in the developing world.

Authors:  B Greenwood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

10.  Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.

Authors:  Tabish Hazir; Shamim A Qazi; Yasir Bin Nisar; Sajid Maqbool; Rai Asghar; Imran Iqbal; Sobia Khalid; Sajid Randhawa; Shazia Aslam; Sobia Riaz; Saleem Abbasi
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.